Literature DB >> 8006276

Current status of myocardial perfusion imaging after percutaneous transluminal coronary angioplasty.

D D Miller1, M S Verani.   

Abstract

Controversy exists with regard to the diagnostic accuracy and optimal technique of myocardial perfusion imaging after coronary angioplasty. Exercise treadmill testing is inexpensive, with adequate predictive value for restenosis and clinical events in patients with single-vessel coronary angioplasty with a normal rest electrocardiogram (ECG). Myocardial tomography has advantages for assessing patients with multivessel coronary angioplasty. Exercise stress imaging is generally preferable to pharmacologic stress in patients without physical limitations after angioplasty. Delayed thallium-201 imaging and reinjection protocols may be useful to reconcile whether residual ischemia exists in "fixed" perfusion defects. Appropriately timed stress myocardial perfusion imaging 2 to 4 weeks after procedurally successful coronary angioplasty can document improved cardiac functional capacity and reduced ECG and imaging evidence of myocardial ischemia. Although routine serial postangioplasty evaluations cannot be recommended, stress myocardial imaging may be valuable in subjects with defective anginal nociception or extensive myocardium at risk in the area subtended by the angioplasty vessel.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8006276     DOI: 10.1016/0735-1097(94)90572-x

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  8 in total

1.  Functional assessment of coronary artery stenosis by doppler derived absolute and relative coronary blood flow velocity reserve in comparison with (99m)Tc MIBI SPECT.

Authors:  H J Verberne; J J Piek; R A van Liebergen; K T Koch; J M Schroeder-Tanka; E A van Royen
Journal:  Heart       Date:  1999-10       Impact factor: 5.994

2.  Volatility in the diagnostic markets: is there a "new economy" of testing?

Authors:  D D Miller; L J Shaw
Journal:  J Nucl Cardiol       Date:  2001 Sep-Oct       Impact factor: 5.952

Review 3.  Prognostic value of gated myocardial perfusion SPECT.

Authors:  Leslee J Shaw; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

Review 4.  Myocardial ischemia is a key factor in the management of stable coronary artery disease.

Authors:  Kohichiro Iwasaki
Journal:  World J Cardiol       Date:  2014-04-26

5.  Exercise training early after acute myocardial infarction reduces stress-induced hypoperfusion and improves left ventricular function.

Authors:  Francesco Giallauria; Wanda Acampa; Francesca Ricci; Alessandra Vitelli; Giorgio Torella; Rosa Lucci; Giuseppina Del Prete; Emilia Zampella; Roberta Assante; Giuseppe Rengo; Dario Leosco; Alberto Cuocolo; Carlo Vigorito
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-12-06       Impact factor: 9.236

6.  Detection of coronary artery stenosis after successful percutaneous coronary intervention by dipyridamole stress portable type signal-averaged electrocardiography: a prospective study.

Authors:  Masatsugu Ohe; Teruhisa Yoshida; Tatsuro Hiraki; Manabu Matsumoto; Hitoshi Otsubo; Tomohito Inage; Tsutomu Imaizumi
Journal:  Heart Vessels       Date:  2008-02-14       Impact factor: 2.037

7.  Transthoracic coronary flow reserve and dobutamine derived myocardial function: a 6-month evaluation after successful coronary angioplasty.

Authors:  Silvana Cicala; Maurizio Galderisi; Pasquale Guarini; Arcangelo D'Errico; Pasquale Innelli; Moira Pardo; Giancarlo Scognamiglio; Oreste de Divitiis
Journal:  Cardiovasc Ultrasound       Date:  2004-12-06       Impact factor: 2.062

8.  The Concordance between Myocardial Perfusion Imaging and Coronary Angiography in Detecting Coronary Artery Disease: A Retrospective Study in a Tertiary Cardiac Center at King Abdullah Medical City.

Authors:  Fatma Aboul-Enein; Majed O Aljuaid; Hail T Alharthi; Abdulkarim M Almudhhi; Mohammad A Alzahrani
Journal:  Cardiol Res Pract       Date:  2016-06-27       Impact factor: 1.866

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.